Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Tag: Bacterial Pneumonia
All
Latest
Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read More
Zinc Deficiency Fuels Bacterial Pneumonia Risk
Zinc deficiency may raise the risk of infection by Acinetobacter baumannii, a leading cause of ventilator-associated pneumonia, according to new research.
Read More
Post-marketing Study Confirms Efficacy of Omadacycline for Pneumonia
The study results confirm omadacycline as a safe and effective treatment for moderate to severe community-acquired bacterial pneumonia, demonstrating non-inferiority to moxifloxacin.
Read More
Antibiotics Ineffective for Lower Respiratory Tract Infections
Antibiotics provided no measurable impact on the severity or duration of coughs, even if a bacterial infection was present, in patients seeking care for lower respiratory tract infections.
Read More
Daily Toothbrushing Lowers Rates of Hospital-acquired Pneumonia
Toothbrushing also is associated with lower rates of ICU mortality, shorter duration of mechanical ventilation, and shorter ICU length of stay.
Read More
Are Dentures a Hidden Risk for Pneumonia?
New research has identified a possible link between wearing dentures and pneumonia.
Read More
Innoviva’s Bacterial Pneumonia Treatment Secures FDA Approval
Xacduro was approved for intravenous use in patients 18 years of age and older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
Read More
Aerosolized mRNA Pneumonia Treatment Improved Symptoms in Preclinical Study
mRNA encoding immunomodulatory proteins IκBα-SR and SOD3 ameliorated symptoms in a bacterial pneumonia model.
Read More
Making VAEs a ‘Never’ Event
With rumors that VAEs could be added to the CMS never event list (which leads to no reimbursement), medical institutions have even more vested interest in preventing these conditions.
Read More
Evidence Points to Viral, Not Bacterial Causes for Community-Acquired Pneumonia in Children
According to the findings of a recent study, cases of community-acquired pneumonia were frequently the result of viral infections, especially RSV, among children and adolescents.
Read MoreAtypical Pneumonia
Atypical pathogens are now responsible for almost 50% of pneumonia cases.
Read More